Literature DB >> 1941575

Bioavailability of a poorly water-soluble drug from tablet and solid dispersion in humans.

P C Sheen, S I Kim, J J Petillo, A T Serajuddin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1941575     DOI： 10.1002/jps.2600800722

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  8 in total

1.  A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug.

Authors:  V Pillay; R Fassihi
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  Monitoring tablet surface roughness during the film coating process.

Authors:  Paulus Seitavuopio; Jyrki Heinämäki; Jukka Rantanen; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2006-04-07       Impact factor: 3.246

Review 3.  Impact of excipient interactions on drug bioavailability from solid dosage forms.

Authors:  Ravikiran Panakanti; Ajit S Narang
Journal:  Pharm Res       Date:  2012-05-19       Impact factor: 4.200

4.  Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules.

Authors:  Manish K Gupta; Yin-Chao Tseng; David Goldman; Robin H Bogner
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

5.  Oral formulation of a novel antiviral agent, PG301029, in a mixture of gelucire 44/14 and DMA (2:1, wt/wt).

Authors:  Yan He; Jennifer L H Johnson; Samuel H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2005-04-08       Impact factor: 3.246

6.  In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs.

Authors:  Makoto Kataoka; Yoshie Masaoka; Yukako Yamazaki; Toshiyasu Sakane; Hitoshi Sezaki; Shinji Yamashita
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

7.  A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development.

Authors:  Hetal N Prajapati; Damon M Dalrymple; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2011-08-23       Impact factor: 4.200

Review 8.  Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives.

Authors:  Hamid Rashidzadeh; Hossein Danafar; Hossein Rahimi; Faezeh Mozafari; Marziyeh Salehiabar; Mohammad Amin Rahmati; Samaneh Rahamooz-Haghighi; Navid Mousazadeh; Ali Mohammadi; Yavuz Nuri Ertas; Ali Ramazani; Irada Huseynova; Rovshan Khalilov; Soodabeh Davaran; Thomas J Webster; Taras Kavetskyy; Aziz Eftekhari; Hamed Nosrati; Mehdi Mirsaeidi
Journal:  Nanomedicine (Lond)       Date:  2021-03-08       Impact factor: 5.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.